|
|
|
|
Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, significantly impacts cell growth and product yield, necessitating careful control and understanding of these scale-dependent effects to enable successful biopharmaceutical manufacturing and technology transfer.
|
|
|
|
|
The integration of predictive modeling into bioprocess automation and control systems is transforming the biopharmaceutical industry. Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
|
|
|
|
|
Combining Functional Design of Experiments (DOE) with traditional DOE methods offers a robust framework to enhance biopharmaceutical production. This approach improves understanding of critical parameters, enabling optimized production, better product quality, and greater process efficiency.
|
|
|
|
|
|
|
|
|
|
|
